Primary care
Recommendation 1
Filgrastim (Neupogen)
Agranulocytosis (Acquired)
Not yet reviewedThis information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.
Disease overview
A rare, drug-induced blood disorder.
Common symptoms
Malaise and granulocytopenia [ ]
When to suspect
Recommendation 1
Thorough history with tests to confirm abnormally low levels of granulocytes in the circulating blood.
How to test
Recommendation 1
Thorough history with tests to confirm abnormally low levels of granulocytes in the circulating blood.
ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.
Treatment
Recommendation 1
Filgrastim (Neupogen)
Further support
Recommendation 1
None currently available. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.
Clinical trials
Clinical Trials
Sources
No data available
Interested in learning more about Agranulocytosis (Acquired)?
Follow to receive regular updates to the latest research development on this disease via email newsletter.